CELC

11.95

1.96% 0.23

Handel nachbörslich: 11.95

Celcuity Inc (CELC)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$11.72

Offen:

$11.7

24-Stunden-Volumen:

209.98K

Relative Volume:

0.79

Marktkapitalisierung:

$443.70M

Einnahmen:

Nettoeinkommen (Verlust:

$-63.78M

KGV:

-4.459

EPS:

-2.68

Netto-Cashflow:

$-53.91M

1W Leistung:

+4.64%

1M Leistung:

-8.71%

6M Leistung:

-34.81%

1J Leistung:

-20.86%

1-Tages-Spanne:

$11.57

$12.36

1-Wochen-Bereich:

$10.96

$12.36

52-Wochen-Spanne:

$10.35

$22.19

Celcuity Inc Stock (CELC) Company Profile

Firmenname

Celcuity Inc

Sektor

Healthcare (1173)

Branche

Biotechnology (678)

Telefon

763-392-0767

Adresse

16305 36TH AVENUE N, MINNEAPOLIS, MN

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

CELC's Discussions on Twitter

Vergleichen Sie CELC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CELC Celcuity Inc	11.95	443.70M	0	-63.78M	-53.91M	-2.68
VRTX Vertex Pharmaceuticals Inc	461.68	118.90B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	672.98	73.95B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	655.13	39.81B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	271.31	34.99B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	123.77	29.67B	3.30B	-501.07M	1.03B	-2.1146

Celcuity Inc Stock (CELC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-07-22	Eingeleitet	Leerink Partners	Outperform
2024-02-22	Eingeleitet	Stifel	Buy
2023-12-08	Eingeleitet	H.C. Wainwright	Buy
2021-10-08	Eingeleitet	Canaccord Genuity	Buy
2021-09-07	Eingeleitet	Jefferies	Buy
2021-07-29	Eingeleitet	Cowen	Outperform
2021-07-27	Eingeleitet	Needham	Buy
2021-01-28	Bestätigt	H.C. Wainwright	Buy
2020-12-24	Bestätigt	H.C. Wainwright	Buy
2020-05-11	Fortgesetzt	Craig Hallum	Buy
2018-11-20	Eingeleitet	H.C. Wainwright	Buy

Alle ansehen

Celcuity Inc Aktie (CELC) Neueste Nachrichten

Jan 24, 2025

When (CELC) Moves Investors should Listen - Stock Traders Daily

Jan 24, 2025

Jefferies lifts Celcuity stock target to $33, maintains Buy rating - MSN

Jan 24, 2025

Jan 23, 2025

Jefferies lifts Celcuity stock target to $33, maintains Buy rating By Investing.com - Investing.com Australia

Jan 23, 2025

Jan 18, 2025

Hennion & Walsh Asset Management Inc. Buys 71,006 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Jan 18, 2025

Jan 17, 2025

Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Analysts - Defense World

Jan 17, 2025

Jan 16, 2025

Celcuity Inc. (NASDAQ:CELC) Holdings Raised by Barclays PLC - Defense World

Jan 16, 2025

Celcuity Inc. (NASDAQ:CELC) Shares Bought by Barclays PLC - MarketBeat

Jan 16, 2025

Jan 14, 2025

Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Average PT from Brokerages - MarketBeat

Jan 14, 2025

Analyzing Celcuity (NASDAQ:CELC) and CannLabs (OTCMKTS:CANL) - Defense World

Jan 14, 2025

Jan 13, 2025

Jane Street Group LLC Sells 9,921 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World

Jan 13, 2025

Jan 10, 2025

Celcuity stock touches 52-week low at $11.51 amid market challenges - Investing.com Australia

Jan 10, 2025

Jan 03, 2025

Objective long/short (CELC) Report - Stock Traders Daily

Jan 03, 2025

Jan 02, 2025

Geode Capital Management LLC Acquires 136,518 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Jan 02, 2025

Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Geode Capital Management LLC - Defense World

Jan 02, 2025

Jan 01, 2025

State Street Corp Purchases 668,318 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 25, 2024

Dec 23, 2024

How to Take Advantage of moves in (CELC) - Stock Traders Daily

Dec 23, 2024

Celcuity Inc. (NASDAQ:CELC) Receives $29.17 Consensus Target Price from Analysts - Defense World

Dec 23, 2024

Dec 20, 2024

Celcuity Inc. (NASDAQ:CELC) Given Average Rating of "Buy" by Analysts - MarketBeat

Dec 20, 2024

Wellington Management Group LLP Makes New Investment in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 20, 2024

Dec 17, 2024

Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionCelcuity (NASDAQ:CELC), Apellis Pharmaceuticals (NASDAQ:APLS) - Benzinga

Dec 17, 2024

Celcuity (CELC) Charges Forward with Promising Potential Cancer Treatments - TipRanks

Dec 17, 2024

Dec 16, 2024

Celcuity Inc. (NASDAQ:CELC) Short Interest Update - MarketBeat

Dec 16, 2024

Dec 15, 2024

Charles Schwab Investment Management Inc. Purchases 153,712 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World

Dec 15, 2024

Dec 13, 2024

(CELC) Investment Report - Stock Traders Daily

Dec 13, 2024

BNP Paribas Financial Markets Raises Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 13, 2024

BNP Paribas Financial Markets Has $673,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World

Dec 13, 2024

Dec 11, 2024

Celcuity reports survival data for breast cancer drug - Investing.com

Dec 11, 2024

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium - The Manila Times

Dec 11, 2024

Celcuity Presents Overall Survival Data from Phase 1b Study - GlobeNewswire

Dec 11, 2024

Verition Fund Management LLC Reduces Holdings in Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Dec 11, 2024

Nov 30, 2024

Braidwell LP Buys 367,663 Shares of Celcuity Inc. (NASDAQ:CELC) - MarketBeat

Nov 30, 2024

Nov 25, 2024

Celcuity Inc. (NASDAQ:CELC) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Nov 25, 2024

Nov 21, 2024

(CELC) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 21, 2024

Nov 18, 2024

Celcuity’s (CELC) “Buy” Rating Reiterated at Needham & Company LLC - Defense World

Nov 18, 2024

Celcuity’s (CELC) “Buy” Rating Reiterated at HC Wainwright - Defense World

Nov 18, 2024

Nov 16, 2024

Celcuity (NASDAQ:CELC) Receives "Buy" Rating from HC Wainwright - MarketBeat

Nov 16, 2024

Nov 15, 2024

Celcuity stock hits 52-week low at $12.14 amid market shifts - Investing.com

Nov 15, 2024

500: Something went wrong - Investing.com India

Nov 15, 2024

Earnings call: Celcuity reports Q3 2024 financials and clinical trial updates - Investing.com

Nov 15, 2024

Celcuity's (CELC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat

Nov 15, 2024

Celcuity Inc. (NASDAQ:CELC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

RA Capital Management, L.P. Acquires New Stake in Celcuity Inc - GuruFocus.com

Nov 15, 2024

COMMODORE CAPITAL LP's Strategic Acquisition of Celcuity Inc Sha - GuruFocus.com

Nov 15, 2024